Medpage Today on MSN22h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
CDC declares 'high severity' of flu cases for all ages
All age groups in the United States are experiencing a "high severity" of influenza cases among all age groups for the first ...
Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
15:30 Kickoffs: Big wins for Bochum and Gladbach, Wolfsburg and Freiburg snatch late winners
Borussia DortmundAs smoke emerging from the travelling Borussia Dortmund contingent emerged, it was Bochum who had the better ...
‘First of its kind’ medication can significantly reduce heart attacks and strokes
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
TAG24 on MSN15m
Certain contraceptives linked to small risk of heart attack, stroke
Certain contraceptives may carry a slightly increased risk of heart attacks and strokes in women, according to a large new study.While the overall risk is very low, researchers said medics should be ...
Everyday Health on MSN23h
Mini-Stroke May Be as Harmful to Long-Term Brain Health as a Full Stroke
People who have a transient ischemic attack (TIA) should get aggressive treatment to help protect cognitive health, a new study suggests.